share_log

Aoxin Q & M Anticipates Rebound in H1 2024

Aoxin Q & M Anticipates Rebound in H1 2024

傲新Q&m預計2024上半年有所反彈
Singapore Business Review ·  08/01 03:01

The company reported a net loss of $210m in H1 2023.

公司在2023年上半年報告了21000萬元的淨虧損。

Aoxin Q & M Dental Group said it anticipates its January to June (H1 2024) net earnings to improve on a year-on-year basis, compared to the net loss recorded last year.

Aoxin Q&M牙科集團表示,預計其2024年1月至6月(2024年上半年)淨利潤將與去年同期相比有所改善,與去年記錄的淨虧損相比。

The rebound is heavily influenced by "the increase in revenue generated from primary healthcare and laboratory services as well as a general reduction in expenses."

復甦受到“初級醫療保健和實驗室服務收入增長以及一般支出減少”的影響。

In the preceding half year, the company narrowed its net loss to $210,000 (CNY1.15m).

在前一半年,公司將淨虧損縮小至210,000美元(人民幣1.15萬元)。

The profit guidance follows a preliminary review of the company's unaudited financial results for H1 2024. Full details will be disclosed on or before 14 August.

利潤指導基於公司2024年上半年未經審計的財務結果的初步審查。完整細節將在8月14日或之前披露。

($1.00 = CNY5.41)

(1.00美元=5.41人民幣)

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論